Oak Grove Capital LLC Abb Vie Inc. Call Options Transaction History

Oak Grove Capital LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $71,610 - $78,834	-700 Reduced 87.5%	100 $2,000
Q4 2020 Feb 17, 2021	SELL	$80.49 - $108.67 $16,097 - $21,734	-200 Reduced 20.0%	800 $3,000
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $68,728 - $80,664	800 Added 400.0%	1,000 $0
Q2 2020 Aug 24, 2020	BUY	$73.37 - $98.18 $14,674 - $19,636	200 New	200 $2,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Oak Grove Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Oak Grove Capital LLC with notifications on news.